These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15288243)

  • 1. Integrating virtual screening in lead discovery.
    Oprea TI; Matter H
    Curr Opin Chem Biol; 2004 Aug; 8(4):349-58. PubMed ID: 15288243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening in lead discovery and optimization.
    Jain AN
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual Discovery Europe--Select Biosciences Conference. Computer-aided drug design and screening.
    Kubinyi H
    IDrugs; 2007 Dec; 10(12):869-73. PubMed ID: 18041683
    [No Abstract]   [Full Text] [Related]  

  • 5. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B
    Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening.
    Kalliokoski T; Salo HS; Lahtela-Kakkonen M; Poso A
    J Chem Inf Model; 2009 Dec; 49(12):2742-8. PubMed ID: 19928753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H; Li M; Choi J; Cho H; Ham SW
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved lead-finding for kinase targets using high-throughput docking.
    McInnes C
    Curr Opin Drug Discov Devel; 2006 May; 9(3):339-47. PubMed ID: 16729730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-aided design of chiral ligands. Part III. A novel ligand for asymmetric allylation designed using computational techniques.
    Kozlowski MC; Waters SP; Skudlarek JW; Evans CA
    Org Lett; 2002 Dec; 4(25):4391-3. PubMed ID: 12465895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based virtual screening protocols.
    Good A
    Curr Opin Drug Discov Devel; 2001 May; 4(3):301-7. PubMed ID: 11560062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based drug metabolism predictions for drug design.
    Sun H; Scott DO
    Chem Biol Drug Des; 2010 Jan; 75(1):3-17. PubMed ID: 19878193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discovery of Kv1.5 blockers as a case study for the application of virtual screening approaches.
    Pirard B; Brendel J; Peukert S
    J Chem Inf Model; 2005; 45(2):477-85. PubMed ID: 15807513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based approaches to drug design and virtual screening.
    Waszkowycz B
    Curr Opin Drug Discov Devel; 2002 May; 5(3):407-13. PubMed ID: 12058616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
    Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
    Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening and prediction of site of metabolism for cytochrome P450 1A2 ligands.
    Vasanthanathan P; Hritz J; Taboureau O; Olsen L; Jørgensen FS; Vermeulen NP; Oostenbrink C
    J Chem Inf Model; 2009 Jan; 49(1):43-52. PubMed ID: 19099399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.